[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]
- PMID: 32064853
- DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]
Abstract
Objective: An outbreak of 2019 novel coronavirus diseases (COVID-19) in Wuhan, China has spread quickly nationwide. Here, we report results of a descriptive, exploratory analysis of all cases diagnosed as of February 11, 2020. Methods: All COVID-19 cases reported through February 11, 2020 were extracted from China's Infectious Disease Information System. Analyses included: 1) summary of patient characteristics; 2) examination of age distributions and sex ratios; 3) calculation of case fatality and mortality rates; 4) geo-temporal analysis of viral spread; 5) epidemiological curve construction; and 6) subgroup analysis. Results: A total of 72 314 patient records-44 672 (61.8%) confirmed cases, 16 186 (22.4%) suspected cases, 10567 (14.6%) clinical diagnosed cases (Hubei only), and 889 asymptomatic cases (1.2%)-contributed data for the analysis. Among confirmed cases, most were aged 30-79 years (86.6%), diagnosed in Hubei (74.7%), and considered mild/mild pneumonia (80.9%). A total of 1 023 deaths occurred among confirmed cases for an overall case-fatality rate of 2.3%. The COVID-19 spread outward from Hubei sometime after December 2019 and by February 11, 2020, 1 386 counties across all 31 provinces were affected. The epidemic curve of onset of symptoms peaked in January 23-26, then began to decline leading up to February 11. A total of 1 716 health workers have become infected and 5 have died (0.3%). Conclusions: The COVID-19 epidemic has spread very quickly. It only took 30 days to expand from Hubei to the rest of Mainland China. With many people returning from a long holiday, China needs to prepare for the possible rebound of the epidemic.
目的: 新型冠状病毒肺炎在武汉暴发流行以来,已在全国范围内蔓延。对截至2020年2月11日中国内地报告所有病例的流行病学特征进行描述和分析。 方法: 选取截至2020年2月11日中国内地传染病报告信息系统中上报所有新型冠状病毒肺炎病例。分析包括:①患者特征;②病死率;③年龄分布和性别比例;④疾病传播的时空特点;⑤所有病例、湖北省以外病例和医务人员病例的流行病学曲线。 结果: 中国内地共报告72 314例病例,其中确诊病例44 672例(61.8%),疑似病例16 186例(22.4%),临床诊断病例10 567例(14.6%),无症状感染者889例(1.2%)。在确诊病例中,大多数年龄在30~79岁(86.6%),湖北省(74.7%),轻/中症病例为主(80.9%)。确诊病例中,死亡1 023例,粗病死率为2.3%。个案调查结果提示,疫情在2019年12月从湖北向外传播,截至2020年2月11日,全国31个省的1 386个县区受到了影响。流行曲线显示在1月23-26日达到峰值,并且观察到发病数下降趋势。截至2月11日,共有1 716名医务工作者感染,其中5人死亡,粗病死率为0.3%。 结论: 新型冠状病毒肺炎传播流行迅速,从首次报告病例日后30 d蔓延至31个省(区/市),疫情在1月24-26日达到首个流行峰,2月1日出现单日发病异常高值,而后逐渐下降。随着人们返回工作岗位,需积极应对可能出现的疫情反弹。.
Keywords: 2019 Novel Coronavirus; Epidemiological characteristics; Outbreak.
Comment in
-
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).Eur J Intern Med. 2020 May;75:107-108. doi: 10.1016/j.ejim.2020.03.014. Epub 2020 Mar 16. Eur J Intern Med. 2020. PMID: 32192856 Free PMC article. No abstract available.
-
ECMO for ARDS due to COVID-19.Heart Lung. 2020 Jul-Aug;49(4):348-349. doi: 10.1016/j.hrtlng.2020.03.012. Epub 2020 Mar 26. Heart Lung. 2020. PMID: 32223988 Free PMC article. No abstract available.
-
Older people and epidemics: a call for empathy.Age Ageing. 2020 Apr 27;49(3):493. doi: 10.1093/ageing/afaa060. Age Ageing. 2020. PMID: 32227214 Free PMC article. No abstract available.
-
Letter to the Editor: Issues on COVID-19 Pathogenesis.Viral Immunol. 2021 Jun;34(5):358-360. doi: 10.1089/vim.2020.0059. Epub 2020 Apr 27. Viral Immunol. 2021. PMID: 32339089 No abstract available.
Similar articles
-
Data-based analysis, modelling and forecasting of the COVID-19 outbreak.PLoS One. 2020 Mar 31;15(3):e0230405. doi: 10.1371/journal.pone.0230405. eCollection 2020. PLoS One. 2020. PMID: 32231374 Free PMC article.
-
Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings.Clin Infect Dis. 2020 Sep 12;71(6):1454-1460. doi: 10.1093/cid/ciaa390. Clin Infect Dis. 2020. PMID: 32255183 Free PMC article.
-
[An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):139-144. doi: 10.3760/cma.j.issn.0254-6450.2020.02.002. Zhonghua Liu Xing Bing Xue Za Zhi. 2020. PMID: 32057211 Review. Chinese.
-
Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.Emerg Infect Dis. 2020 Jun;26(6):1251-1256. doi: 10.3201/eid2606.200233. Epub 2020 Jun 17. Emerg Infect Dis. 2020. PMID: 32168464 Free PMC article.
-
Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.Arch Gynecol Obstet. 2020 Sep;302(3):545-551. doi: 10.1007/s00404-020-05573-8. Epub 2020 Jul 21. Arch Gynecol Obstet. 2020. PMID: 32696241 Free PMC article. Review.
Cited by
-
Impact of High Troponin Level on the Outcome in COVID-19 Positive Patients.J Multidiscip Healthc. 2024 Nov 1;17:4989-5000. doi: 10.2147/JMDH.S489622. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39503002 Free PMC article.
-
Long-term Impacts of Long COVID: Increased Incidence of Cardiomyopathies, Joint Diseases, and Psychoanxiety Disorders.In Vivo. 2024 Nov-Dec;38(6):3022-3032. doi: 10.21873/invivo.13786. In Vivo. 2024. PMID: 39477428 Free PMC article.
-
HLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection.Life (Basel). 2024 Sep 19;14(9):1181. doi: 10.3390/life14091181. Life (Basel). 2024. PMID: 39337964 Free PMC article.
-
Role of vitamin D in COVID-19 and other viral infections.World J Virol. 2024 Sep 25;13(3):95349. doi: 10.5501/wjv.v13.i3.95349. World J Virol. 2024. PMID: 39323448 Free PMC article. Review.
-
Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China.BMC Infect Dis. 2024 Jul 18;24(1):706. doi: 10.1186/s12879-024-09287-z. BMC Infect Dis. 2024. PMID: 39026159 Free PMC article.
MeSH terms
Grants and funding
- 2018ZX10201002-008-002/Research Based on Epidemic Law of Animal-derived Influenza and Related Influencing Factors, National Science and Technology Foundation of China
- 71934002/Research on Public Health Risk Prevention and Model Innovation under the Background of "the belt and road initiative", National Natural Science Foundation of China
- 2018ZX10201002- 008-002/Research Based on Epidemic Law of Animal-derived Influenza and Related Influencing Factors, National Science and Technology Foundation of China
LinkOut - more resources
Full Text Sources
Other Literature Sources

